Rotavirus Vaccination in India: Current Status and Future Needs
Author Information
Author(s): Niranjan Bhat, Elisabeth Vodicka, Allison Clifford, Ananth Kanduri Balaji, Ashish Bavdekar, Arup Deb Roy, Umesh Parashar, Jacqueline Tate, Pradeep Haldar, Gagandeep Kang
Primary Institution: Center for Vaccine Innovation and Access, PATH
Hypothesis
What is the current evidence base for rotavirus vaccination in India and what future research is needed?
Conclusion
The evidence base for rotavirus vaccination in India is solid, with no major gaps identified, but additional smaller-scale studies could enhance understanding of vaccine performance.
Supporting Evidence
- Rotavirus is a leading cause of severe diarrhea in children worldwide.
- India has introduced two rotavirus vaccines into its immunization program.
- Post-introduction evaluations have shown a reduction in rotavirus hospitalization rates.
Takeaway
Rotavirus vaccines help protect kids from severe diarrhea, and India has done a good job with their vaccination program, but more research can help make it even better.
Methodology
Literature review and consultation with stakeholders including government and research institutions.
Limitations
The study primarily focused on existing data and may not cover all aspects of vaccine performance in diverse settings.
Participant Demographics
The study involved children under five years of age hospitalized for diarrhea.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website